Finance

Lists
000403:SHE
Pacific Shuanglin Bio-pharmacy Co Ltd
9,55 CNY
-0,10%
(-0,010) 1D
16 ოქტ, 14:10:27 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000403...
Open
9,62 CNY
High
9,79 CNY
Low
9,55 CNY
Mkt. cap
9,22 მლრდ.
Avg. vol.
5,57 მლნ.
Volume
4,31 მლნ.
P/E ratio
33,98
52-wk high
16,58 CNY
52-wk low
8,54 CNY
EPS
0,28 CNY
Shares outstanding
950,40 მლნ.
No. of employees
3 ათ.
Open
9,62 CNY
High
9,79 CNY
Low
9,55 CNY
Mkt. cap
9,22 მლრდ.
Avg. vol.
5,57 მლნ.
Volume
4,31 მლნ.
P/E ratio
33,98
52-wk high
16,58 CNY
52-wk low
8,54 CNY
EPS
0,28 CNY
Shares outstanding
950,40 მლნ.
No. of employees
3 ათ.
News stories
From web sources and news partners
About Pacific Shuanglin Bio-pharmacy Co Ltd
CEO-
Employees2,76 ათ.
Founded1993
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
631,66 მლნ.
1,01 მლრდ.
342,92 მლნ.
486,92 მლნ.
Cost of goods sold
345,25 მლნ.
674,87 მლნ.
223,50 მლნ.
333,55 მლნ.
Cost of revenue
345,25 მლნ.
674,87 მლნ.
223,50 მლნ.
333,55 მლნ.
Research and development expenses
12,11 მლნ.
25,01 მლნ.
10,34 მლნ.
6,09 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
142,84 მლნ.
120,55 მლნ.
83,99 მლნ.
76,71 მლნ.
Operating expense
161,42 მლნ.
162,30 მლნ.
98,57 მლნ.
90,31 მლნ.
Total operating expenses
506,67 მლნ.
837,17 მლნ.
322,07 მლნ.
423,86 მლნ.
Operating income
124,99 მლნ.
177,29 მლნ.
20,85 მლნ.
63,06 მლნ.
Other non operating income
-236,66 ათ.
-32,79 ათ.
-2,74 მლნ.
2,22 მლნ.
EBT including unusual items
138,01 მლნ.
93,36 მლნ.
29,08 მლნ.
69,80 მლნ.
EBT excluding unusual items
134,60 მლნ.
178,56 მლნ.
28,71 მლნ.
70,38 მლნ.
Income tax expense
16,43 მლნ.
31,33 მლნ.
6,34 მლნ.
7,56 მლნ.
Effective tax rate
11,90%
33,55%
21,82%
10,83%
Other operating expenses
5,57 მლნ.
7,62 მლნ.
6,17 მლნ.
5,92 მლნ.
Net income
121,39 მლნ.
62,09 მლნ.
22,97 მლნ.
61,33 მლნ.
Net profit margin
19,22%
6,12%
6,70%
12,60%
Earnings per share
-
-
-
-
Interest and investment income
15,61 მლნ.
6,69 მლნ.
15,52 მლნ.
11,30 მლნ.
Interest expense
-5,76 მლნ.
-5,39 მლნ.
-4,92 მლნ.
-6,20 მლნ.
Net interest expenses
9,85 მლნ.
1,29 მლნ.
10,60 მლნ.
5,09 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
155,19 მლნ.
210,35 მლნ.
53,91 მლნ.
100,07 მლნ.
Gain or loss from assets sale
785,80 ათ.
-756,00 ათ.
-
135,62 ათ.
AI content may include mistakes. Learn more
Google აპები